Regarding human HCC, tumors with gp130 mutations always display an additional activating mutation of the β-catenin pathway, indicating that additional hits are required for malignant transformation of hepatocytes with forced gp130 activation [8]. The gene discussed is IL6ST; the disease is hepatocellular carcinoma.